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ARTICLE
Generation and trapping of a mesoderm biased
state of human pluripotency
Dylan Stavish 1✉, Charlotta Böiers 2, Christopher Price 1, Thomas J. R. Frith 1, Jason Halliwell 1,
Ingrid Saldaña-Guerrero 1, Jason Wray2, John Brown 2, Jonathon Carr1, Chela James2, Ivana Barbaric1,
Peter W. Andrews 1✉ & Tariq Enver2
We postulate that exit from pluripotency involves intermediates that retain pluripotency
while simultaneously exhibiting lineage-bias. Using a MIXL1 reporter, we explore mesoderm
lineage-bias within the human pluripotent stem cell compartment. We identify a substate,
which at the single cell level coexpresses pluripotent and mesodermal gene expression
programmes. Functionally these cells initiate stem cell cultures and exhibit mesodermal bias
in differentiation assays. By promoting mesodermal identity through manipulation of WNT
signalling while preventing exit from pluripotency using lysophosphatidic acid, we ‘trap’ and
maintain cells in a lineage-biased stem cell state through multiple passages. These cells
correspond to a normal state on the differentiation trajectory, the plasticity of which is
evidenced by their reacquisition of an unbiased state upon removal of differentiation cues.
The use of ‘cross-antagonistic’ signalling to trap pluripotent stem cell intermediates with
different lineage-bias may have general applicability in the efficient production of cells for
regenerative medicine.
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esearch of pluripotent stem cells (PSC), whether embryonic
stem cells or induced pluripotent stem (IPS) cells, has often
centred on robustly maintaining pluripotency. Less well
investigated is how cells leave the pluripotent stem cell com-
partment. This is central for a biological understanding of how
differentiation is regulated and lineage is specified. Since the use
of pluripotent cells in regenerative medicine requires the efficient
production of differentiated derivatives, delineating the cellular
trajectories by which cells transit from pluripotency into lineage
commitment is key. The existence of developmental inter-
mediates on this trajectory may, in part, account for the cellular
heterogeneity exhibited by in vitro cultures of human PSC1.
Heterogeneity has been described in respect of: (i) Subsets of
cells with different self renewal potential2,3 identified based on
surface antigen expression; and (ii) subsets with differential
expression of lineage affiliated genes have been described; criti-
cally single cell studies have shown these to coexist with stem cell
programmes4–6. Importantly, experimental assays of differentia-
tion have demonstrated that these patterns of gene expression
reflect interconvertible substates that functionally encode differ-
ential lineage bias within the stem cell compartment4,5,7. Reporter
gene strategies have been particularly useful in this regard. We
recently showed, using a fluorescent reporter, that a substate of
human PSC expressed the early endoderm related marker
GATA64. GATA6 positive cells were able to regenerate long-term
pluripotent cultures yet their spontaneous differentiation
favoured endodermal lineages. That study supports the notion—
at least for endoderm—that these substates, which coexpress
signatures of pluripotency and differentiation represent differ-
entiation intermediates, may exist normally as transient states.
Whether these exist for other lineages is not yet known. It is
noteworthy that the pluripotent state of human PSC is itself also
transient in development and is in effect trapped when human
PSC are cultured in vitro. Recently, culture systems that aim to
trap cells in an earlier naïve stage of development has been
reported8–10, but whether cells can be trapped further along a
particular differentiation trajectory has been less well explored.
Cross-antagonism of pro-pluripotency and pro-differentiation
signalling in a controlled environment could potentially provide a
strategy allowing for the propagation of a pluripotent inter-
mediate with a specific lineage bias.
Herein we use a MIXL1 reporter11 to delineate the cellular
trajectory from pluripotency to committed mesoderm progeni-
tors. On this trajectory, we identify within the stem cell com-
partment a developmental intermediate that also exhibits
mesoderm lineage bias. Using a cross antagonism strategy, we can
trap and expand this intermediate while retaining its capacity to
revert to an unbiased stem cell state. The identification and
characterisation of mesodermal biased pluripotent intermediates
informs our understanding of how mesoderm lineage specifica-
tion occurs and could provide an attractive starting point for
directed differentiation towards mesodermal derivatives.
Results
Identifying substates expressing MIXL1-GFP in feeder culture.
The expression of MIXL1 in early differentiation of human PSC
towards mesodermal derivatives12 identified it as a candidate gene
to assess for early lineage biased substates. We utilised the MIXL1
reporter line engineered by Davis et al.11, which has an enhanced
GFP sequence inserted into the first exon of one of the MIXL1
alleles of the HES3 human PSC line. This line has been used
previously by many others investigating differentiation of human
PSC, without any overt effects of the reporter’s presence11–15.
Throughout this paper, we have used expression of GFP as a
measure of the MIXL1 transcriptional state, which we refer to
throughout the manuscript as MIXL1-GFP. When cultures of the
MIXL1 reporter (HES3-MIXL1) were grown on mouse embryo
fibroblast (MEF) feeder cells in medium containing Knock-out
Serum Replacement (MEF/KOSR condition), they typically con-
tained a subpopulation of 5–20% of cells that co-expressed
MIXL1 and SSEA-3, a surface antigen that we have previously
used as a sensitive marker of undifferentiated stem cells3,16,17
(Fig. 1a).
To examine the relationship of these MIXL1-GFP(+)/SSEA-3
(+) cells to the other subpopulations of MIXL1-GFP(−)/SSEA-3
(+) and MIXL1-GFP(+)/SSEA-3(−) cells, putatively stem and
differentiated cells, respectively, and to test whether they co-
express other markers that are separately indicators of a
differentiated or undifferentiated state, we carried out RNA
sequencing (RNAseq) analysis of these three subpopulations,
isolated by fluorescence-activated cell sorting (FACS). The
expression of MIXL1-GFP correlated well with the MIXL1 gene
expression in the RNAseq data (Supplementary Fig. S1a).
Principle component analysis (PCA) of the entire transcriptomes
from these RNAseq data showed a clear separation of the three
subpopulations (Fig. 1b). In the case of the MIXL1-GFP
(+)/SSEA-3(+) and MIXL1-GFP(−)/SSEA-3(+) cells, data from
two biological replicates of each clustered closely, whereas two
replicates of the MIXL1-GFP(+)/SSEA-3(−) cells were more
separated, perhaps reflecting a great heterogeneity and variability
expected in populations of differentiated cells. On the other hand,
when the PCA was carried out with only a subset of pluripotency
associated genes (Fig. 1c) the MIXL1-GFP(+)/SSEA-3(+) cluster
moved closer to the MIXL1-GFP(−)/SSEA-3(+) cluster, espe-
cially with respect to PC1 which accounts for 89% of variance,
whereas when the PCA was carried out with genes associated with
mesoderm (Fig. 1d) the MIXL1-GFP(+)/SSEA-3(+) cluster
moved closer to the MIXL1-GFP(+)/SSEA-3(−) cluster of
putatively differentiated cells. These analyses suggest that an
active pluripotency network might still be in place the MIXL1-
GFP(+)/SSEA-3(+) cells, consistent with the possibility that they
occupy a substate within the stem cell compartment.
To test this we analysed each subpopulation for the expression
of a signature set of genes (Supplementary Table S1), which
included 3 controls and 45 genes of interest, by single cell qPCR
to assess whether the MIXL1-GFP(+)/SSEA-3(+) subpopulation
includes individual cells that co-express pluripotency and
mesoderm associated genes, and so may represent a transitional
substate between that of pristine, pluripotent MIXL1-GFP
(−)/SSEA-3(+) stem cells and that of mesodermally committed,
differentiated MIXL1-GFP(+)/SSEA-3(−) cells. The 45 gene set
included genes typically associated with the undifferentiated state,
such as OCT4, NANOG, and SOX2, and genes typically associated
with early mesendoderm differentiation, such as T(Brachyury),
EOMES, and GATA6. Using Monocle218 we produced t-
distributed stochastic neighbour embedding (t-SNE) analysis of
these single cell transcriptomic data. This showed that the
MIXL1-GFP(+)/SSEA-3(+) cells cluster separately, spanning the
space between separate clusters of the MIXL1-GFP(−)/SSEA-3
(+) and MIXL1-GFP(+)/SSEA-3(−) cells, though there was
substantial heterogeneity in each cluster (Fig. 1e).
Single cell analysis did reveal a minor disparity in MIXL1
expression as reported by GFP positivity and MIXL1 transcript
levels, as assessed by qPCR, which was not evident from the
RNAseq data. For example, 7 of 72 cells in the MIXL1-GFP(−)
fraction exhibited some level of MIXL1 expression, and
conversely a similar level of discordance was seen in the
MIXL1-GFP(+) cells (Supplementary Fig. S1b). This disparity
has been noted previously11 likely caused by the over 20 h half-
life of the GFP19. Nevertheless, pseudotime analysis of the
single cell qPCR data matched the differentiation trajectory
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that we inferred from reporter gene and surface marker
expression, with MIXL1-GFP(−)/SSEA-3(+) mapping to the
start of pseudotime and MIXL1-GFP(+)/SSEA-3(−) towards the
end (Supplementary Fig. S1c, d). Even though the MIXL1-GFP
andMIXL1 transcript level is not completely correlated, the use of
GFP expression coupled with surface marker expression allowed
for the segregation of states, which pertain to a differentiation
trajectory.
A more detailed analysis using a subset of the 48 genes that
relate most closely to the pluripotent and differentiated states
revealed two main clusters of cells, with the MIXL1-GFP
(−)/SSEA-3(+) and MIXL1-GFP(+)/SSEA-3(−) displaying an
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almost complete separation into Cluster A (Pluripotent) and
Cluster B (Differentiated), respectively (Fig. 1f). By contrast, the
MIXL1-GFP(+)/SSEA-3(+) subpopulation included cells in both
of these clusters, with many cells expressing both pluripotency
and differentiation associated genes (Fig. 1f). For example, many
of the cells in the MIXL1-GFP(+)/SSEA-3(+) fraction co-
expressed the pluripotency associated marker SOX2 and the
mesoderm associated marker T (Fig. 1g). Similar cells were not
often seen in the MIXL1-GFP(−)/SSEA-3(+) or MIXL1-GFP
(+)/SSEA-3(−) fractions. The analysis also highlights the
clustering of expression of the pluripotency associated genes,
POU5F1, SOX2, NANOG, and DNMT3B, whereas MIXL1
clustered most closely with differentiation markers such as T,
FOXA2, and CER1. The expression of the full panel of genes
assessed is shown in Supplementary Fig. S2. These data suggest
that the MIXL1-GFP(+)/SSEA-3(+) cells do occupy a transi-
tional substate in terms of gene expression, but do not identify
whether that substate is part of the stem cell or differentiated cell
compartment.
MIXL1-GFP(+)/SSEA-3(+) cells contain self-renewing ES cells.
To assess whether the MIXL1-GFP(+)/SSEA-3(+) subpopulation
contains functional undifferentiated stem cells, we isolated 288
MIXL1-GFP(+)/SSEA-3(+) individual cells by FACS and single
cell deposition. From these we were able to grow out 47 colonies.
Indexed FACS data confirmed the MIXL1 and SSEA-3 expression
levels of the individual cells from which these colonies were
obtained (Fig. 2a). All of these 47 clonal colonies exhibited a
typical rounded human ES cell colony morphology containing
cells with a high nuclear to cytoplasmic ratio, a representative
colony is shown in Fig. 2b. From these, 44 colonies were passaged
further, and 27 survived; all were positive for the human PSC cell
surface antigen TRA-1-81 (Supplementary Fig. S3a). We then
randomly selected six clones for further expansion to generate six
clonal lines, their original indexed position is shown in Fig. 2a. All
displayed high levels of expression for a panel of typical human
PSC cell surface antigens, BF4, CD9, SSEA-4, TRA-1-60, TRA-1-
81, and TRA-2-49 compared to the negative control P3X (Fig. 2c,
Supplementary Fig. S3c). Expression of the pluripotency asso-
ciated marker, NANOG, was confirmed by intracellular staining
(Supplementary Fig. S3b). Although these clonal lines were all
derived from MIXL1-GFP(+)/SSEA-3(+) cells (Fig. 2a), their
pattern of MIXL1 and SSEA-3 expression in each case had
reverted to the pattern seen in the parental cultures rather than
retaining the MIXL1 positive status of the starting cell (Fig. 2d).
Thus the MIXL1-GFP(+)/SSEA-3(+) subpopulation contains
undifferentiated stem cells, despite their transient expression of
genes associated with differentiation as cells were able to
repopulate a heterogeneous population (Fig. 2e), and that the
MIXL1-GFP(+)/SSEA-3(+) and MIXL1-GFP(−)/SSEA-3(+)
subpopulations represent interconvertible substates of the stem
cell compartment.
Generating MIXL1-GFP(+)/SSEA-3(+) cells in a defined sys-
tem. The MEF/KOSR system is not fully defined depending on
proprietary components and the use of mouse fibroblasts as a
feeder layer and the presence of MIXL1-GFP(+)/SSEA-3(+) is
inherently variable in this system (Supplementary Fig. S4). We
tested whether the MIXL1-GFP(+)/SSEA-3(+) subpopulation
existed in completely defined conditions, E8 medium20, with a
vitronectin attachment factor culture conditions. We found that
this subpopulation vanished and no MIXL1-GFP(+)/SSEA-3(+)
cells were detected (Fig. 3a). Since we had noted that an inhibitor
of endogenous WNT secretion, IWP-2, also inhibited the
appearance of MIXL1-GFP(+)/SSEA-3(+) cells in MEF/KOSR
conditions (Supplementary Fig. S5) similar to findings shown
before21, we inferred that the substate might be regulated by
WNT signalling. Therefore, we tested whether activation of WNT
signalling in cells cultured in E8 medium could generate this
subpopulation. Indeed, the GSK3β inhibitor, CHIR99021
(CHIRON), a canonical WNT signalling mimic, did strongly
induce MIXL1 expression but, although initially the MIXL1-GFP
(+) cells also expressed SSEA-3, within three days (72 h) many of
the cells were MIXL1-GFP(+)/SSEA-3(−) (Fig. 3b). However, by
the further addition of varying levels of lysophophatidic acid
(LPA), a promoter of pluripotency22,23, we were able to coun-
teract the inductive action of CHIRON and establish conditions
in which the pro- and anti-differentiation effects were balanced,
so that a substantial proportion of the cells retained expression of
both MIXL1 and SSEA-3 (Fig. 3c). In these exploratory experi-
ments we had also included ROCK inhibitor (Y-27632); subse-
quently, we found this is unnecessary and, in the absence of the
ROCK inhibitor, we established our initial optimal conditions of
3 µM CHIRON and 0.48 µM LPA to form the MIXL1-GFP
(+)/SSEA-3(+) subset.
Although the combination of CHIRON and LPA was able to
generate MIXL1-GFP(+)/SSEA-3(+) cells, its ability to maintain
this level after passaging was variable. We considered that a
possible cause of this variability is the secretion of WNT ligands
by cells undergoing early differentiation and that these compro-
mised the level of LPA that we had optimised to counteract the
effect of the CHIRON. To address this, we tested a system, similar
to the Baseline Activation method proposed in Hackland et al.24,
in which we added the inhibitor of WNT secretion, IWP-2
(Fig. 3d). When the cells were first grown in the presence of 0.48
µM LPA and 3 µM CHIRON and then passaged in the absence of
Fig. 1 A transitionary substate between pluripotency and early mesendodermal differentiation is marked by MIXL1-GFP and SSEA-3 coexpression.
a Flow cytometry scatter plot of MIXL1-GFP and SSEA-3 expression by HES3-MIXL1 cells cultured in MEF/KOSR conditions. Coloured populations indicate
the fractions isolated by FACS for bulk and single cell transcriptomic analysis, MIXL1-GFP(−)/SSEA-3(+) (Red) MIXL1-GFP(+)/SSEA-3(+) (Green),
MIXL1-GFP(+)/SSEA-3(−) (Blue). Principal component analysis (PCA) plots generated from RNAseq data of the MIXL1-GFP(−)/SSEA-3(+), MIXL1-GFP
(+)/SSEA-3(+) and MIXL1-GFP(+)/SSEA-3(−)fractions: b plot generated from all mRNA expression; plots generated from genes associated with
c pluripotency and d mesoderm. e t-SNE plot of the expression of 45 genes (Supplementary Table 1) in individual cells measured by Fluidigm Biomark
qPCR. All fractions are displayed in the same dimensional space:MIXL1-GFP(−)/SSEA-3(+) cells as red squares,MIXL1-GFP(+)/SSEA-3(+) cells as green
circles and MIXL1-GFP(−)/SSEA-3(+) cells as blue triangles. f Heatmap analysis of 232 single cells analysed across 14 of 45 analysed genes using a
Fluidigm BioMark system: hierarchical clustering was performed for the genes assessed. The heatmap visualises the individual gene expression after
normalisation across genes. White coloured genes indicate undetected levels of expression. Single cells are labelled by colour with the fraction from which
they were sorted. Cluster analysis split cells into two broad classification, Cluster A (Pluripotency, Pluri) and Cluster B (Differentiation, Diff). Cells co-
expressing pluripotency and differentiation associated genes were readily detected in the MIXL1-GFP(+)/SSEA-3(+) fraction but not the other fractions.
g Scatter plot of 1/Ct values for each single cell for SOX2 and T expression (MIXL1-GFP(−)/SSEA-3(+) cells as red squares, MIXL1-GFP(+)/SSEA-3(+)
cells as green circles and MIXL1-GFP(−)/SSEA-3(+) cells as blue triangles). A large proportion of MIXL1-GFP(+)/SSEA-3(+) expressed both SOX2 and T.
e–g Source data are provided as a Source Data file.
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IWP-2, there was a marked decrease in expression of SSEA-3.
However, when the medium also contained 1 µM IWP-2 there
was a striking increase in the expression of SSEA-3 after
passaging. These cells from cultures in the presence of IWP-2
also retained expression of other stem cell related antigens and
displayed good colony morphology and growth rate over four
days post passage. The optimisation process (Fig. 3e) lead to our
first medium formulation, which we named PRIMO. The
medium consisted of E8 basal medium plus 0.1% BSA, 2 µM
cholesterol, 3 µM CHIRON, 1 µM IWP-2 and 0.48 µM LPA.
PRIMO medium induced a high proportion of MIXL1-GFP
(+)/SSEA-3(+) cells in cultures (Fig. 3f).
Cells in PRIMO medium express early mesendodermal genes.
To assess how closely the ‘trapped’ MIXL1-GFP(+)/SSEA-3(+)
subset from cells growing in PRIMO medium resembled the
similar subset from MEF/KOSR cultures, we compared the
transcriptomes of MIXL1-GFP(−)/SSEA-3(+) and MIXL1-GFP
(+)/SSEA-3(+) cells grown in PRIMO conditions for 3 days, as
well asMIXL1-GFP(−)/SSEA-3(+) cells from cultures in E8, with
the previous data from cells growing in MEF/KOSR conditions.
By PCA, the bulk RNA sequencing data showed a similarity
between the MIXL1-GFP(+)/SSEA-3(+) cells from both PRIMO
and MEF/KOSR cultures whereas the MIXL1-GFP(−)/SSEA-3
(+) PRIMO fraction showed some separation from its counter
parts in MEF/KOSR and was further separated from the corre-
sponding fraction from E8 cultures (Fig. 4a). We also carried out
a single cell qPCR analysis of expression of the 48 gene-set
analysed previously. When these data were incorporated into the
t-SNE plot previously obtained from the cells growing in MEF/
KOSR conditions, the PRIMO-derived MIXL1-GFP(+)/SSEA-3
(+) cells showed a distribution that largely superimposed on the
MIXL1-GFP(+)/SSEA-3(+) cells from MEF/KOSR condition,
lying between the MIXL1-GFP(−)/SSEA-3(+) and MIXL1-GFP
(+)/SSEA-3(−) cluster (Fig. 4b). The gene signatures from single
cell gene expression patterns from the MIXL1-GFP(+)/SSEA-3
(+) fractions from PRIMO and MEF/KOSR cultures were very
similar (Supplementary Figs. S6 and S7)
To assess how the MIXL1-GFP(+)/SSEA-3(+) cells relate to
the trajectory of ES cell differentiation we added 3 µM CHIRON
to cells growing in E8 medium and isolated the emerging cell
populations at 0, 6, 12, 18, 24, 48 and 72 h, based on MIXL1-GFP
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and SSEA-3 expression (Fig. 4c, Supplementary Fig. S8). Over this
period the expression of MIXL1 gradually increased, preceding
the eventual loss of SSEA-3 expression. Bulk RNAseq data from
the emerging cells at each time point was compared by PCA with
RNAseq data from MIXL1-GFP(−)/SSEA-3(+) and MIXL1-GFP
(+)/SSEA-3(+) cells growing in PRIMO conditions for 3 days
(Fig. 4d). The MIXL1-GFP(+)/SSEA-3(+) fraction mapped
between 24 and 48 h, whereas the MIXL1-GFP(−)/SSEA-3(+)
fraction from PRIMO conditions did not correlate with the zero
hour, MIXL1-GFP(−)/SSEA-3(+) cells from E8 but rather
mapped on the trajectory between 12 and 18 h of differentiation
(Fig. 4d). Thus, the PRIMO medium appears to trap all cells in an
intermediate substate but, interestingly, this substate appears to
be independent of MIXL1-GFP reporter expression. Differential
gene expression analysis by DESeq2 and SeqMonk of cells
growing in PRIMO, pooling data from both MIXL1-GFP(+) and
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MIXL1-GFP(−) cells, compared to E8 revealed upregulation of
differentiation markers while key pluripotency associated markers
such as NANOG, POU5F1 were not differentially expressed
(Fig. 4e). Much like the MIXL1-GFP(+)/SSEA-3(+) cells from
MEF/KOSR (Fig. 1b), our PRIMO cultures showed co-expression
of pluripotency associated genes such as POUF51, NANOG, etc.
and differentiation-associated genes such as MIXL1, T (BRA-
CHYURY), DKK1, etc. (Fig. 4e). Gene ontology enrichment
analysis of the most differentially expressed genes, red squares in
Fig. 4e, revealed an enrichment in biological processes such as
mesoderm development and gastrulation (Fig. 4f).
Assessing the lineage bias of cells grown in PRIMO. After this
initial transcriptomic profiling using PRIMO medium, we found
that the formulation required further optimisation to increase the
maintenance of cells after multiple passages. We developed a
further optimised medium containing a higher level of LPA,
termed PRIMO Plus which consisted of E8 basal medium plus
0.2% BSA, 4 µM cholesterol, 3 µM CHIRON, 1 µM IWP-2 and
0.96 µM LPA. From our previous work on MIXL1-GFP
(+)/SSEA-3(+) cells from feeders we predicted that the same
population in PRIMO Plus could again generate clonal stem cell
lines but also, as our transcriptomic analysis indicated these cells
were on a differentiation trajectory, that their differentiation
would be biased towards mesoderm. To confirm this HES3-
MIXL1 cells grown for 3 days in PRIMO Plus medium were
analysed by cloning and by embryoid body (EB) formation under
‘neutral’ conditions25. The clonal lines established also were used
for EB formation. All EBs were then assessed by transcriptome
signatures and the score card method26 (Fig. 5a).
We obtained 38 stem cell-like colonies from 384 MIXL1-GFP
(+)/SSEA-3(+) cells isolated by FACS and single cell deposition
(Fig. 5b). Of these, 31 colonies survived further passaging and
were positive for TRA-1-81 staining (Supplementary Fig. S9a). Six
of these colonies were randomly selected, initially expanded in
MEF/KOSR conditions (Supplementary Fig. S9b, c), transitioned
into E8 conditions and then were assessed for their expression of
pluripotency associated surface markers expression and MIXL1-
GFP (Supplementary S9d, e); the index position of the parent cells
for each of these expanded lines confirmed that they were derived
from MIXL1-GFP(+)/SSEA-3(+) cells (purple stars in Fig. 5b).
Each of the clones exhibited patterns of antigen expression, and
lack of MIXL1-GFP, expression, similar to the parental cells
growing in E8 conditions (Fig. 5c). These cloning results indicate
that the MIXL1-GFP(+)/SSEA-3(+) cells from cultures in
PRIMO medium do reside within the stem cell compartment
and retain the ability to revert to other stem cell substates.
When these PRIMO-derived clones adapted to growth in E8
were cultured as EBs under neutral conditions they showed
marked down-regulation of stem cell related genes and
upregulation of genes associated with all three germ layers
(Fig. 5d), indicating a capacity for multilineage differentiation
with no obvious bias. The transcriptional time course analysis of
cells in PRIMO showed that both subsets, irrespective of MIXL-
GFP expression, are located on the trajectory of mesoderm
differentiation induced by CHIRON (Fig. 4d). Therefore, we
tested whether these transcriptional changes would lead to
differentiation that favours mesoderm formation. When we
collected MIXL1-GFP(−)/SSEA-3(+) or MIXL1-GFP(+)/SSEA-
3(+) cells by FACS or unsorted cells grown in PRIMO Plus
medium, and grew them as EBs under neutral conditions, they all
showed a marked bias to mesoderm differentiation, irrespective of
MIXL1 expression. Congruent with the transcriptional time
course analysis, EBs showed that cells grown in PRIMO medium
are on a mesoderm trajectory which impacts upon their lineage
fate decision, an impact that was reversible when clonal lines were
established in E8 conditions (Fig. 5d).
Since the cells grown in PRIMO Plus exhibited a mesoderm
bias we also assessed their ability to generate haematopoietic
progenitors, as an example of a particular lineage derived, in this
case, from lateral plate mesoderm. In addition to HES3-MIXL1
we used another human PSC line, H9 T-Venus, that carries a
Venus reporter for T (BRACHYURY) expression27 for this assay.
Cells were first passaged into flasks containing either E8 or
PRIMO Plus media. After three days the cells were replated onto
confluent OP9 mouse stromal cells, while high co-expression of
reporter gene with SSEA-3 and TRA-1-81 was confirmed by
analysis of a sister flask (Supplementary Fig. S10). When analysed
ten days later, for both cell lines, 5–15% more cells from the
PRIMO cultures than from E8 cultures expressed
haematopoiesis-associated molecules CD43 and CD34, assessed
by flow cytometry (Fig. 6a). Taking into account the final
numbers of harvested cells, this equated to a 30–40% increase in
yield (Fig. 6b) of CD43+ cells generated in PRIMO compared to
the E8 conditions (Fig. 6c).
We next used directed EB differentiation towards alternative
germ layers28 to test whether the cells grown in PRIMO Plus
retain full pluripotency, despite their bias towards mesoderm.
Using conditions to direct the EB differentiation of HES3-MIXL1
or H9 T-Venus cells grown in PRIMO media for three passages
towards ectoderm, mesoderm or endoderm we observed
respective lineage signatures, assessed by the hPSC scorecard
method26 (Fig. 6d). To test further the potency of cells
maintained in PRIMO we also assessed whether they could be
induced using a very different, 2D culture method24 to
differentiate into neural crest, a derivative of the embryonic
ectoderm. We were able to generate SOX10 positive neural crest
cells from all three cell lines grown in PRIMO medium (Fig. 6e
and Supplementary Fig. S11) at efficiencies within the published
range24,29. We also found that the use of the WNT inhibitor,
IWP-2, during differentiations towards ectoderm and endoderm
aided efficient differentiation (Fig. 6d), as previously shown13,30.
This was also the case for neural crest formation (Supplementary
Fig. S11c). Together, these results confirm that cells maintained in
Fig. 3 Balancing pro-self-renewal and pro-differentiation signals enables propagation of MIXL1-GFP/SSEA-3 cells. Flow cytometry density plots of
SSEA-3 versus MIXL1-GFP for HES3 MIXL1-GFP cells growing in E8 (a) and E8 with 3 µM CHIRON for 24 hours and 72 h (b). In E8 SSEA-3 is highly
expressed but MIXL1-GFP is not detected. The addition of CHIRON drives MIXL1 expression and eventual loss of SSEA-3. c Flow cytometry density plots
displaying SSEA-3 expression versus MIXL1-GFP expression for HES3 MIXL1-GFP cells grown in E8 medium with 3 µM CHIRON and increasing levels of
LPA, higher levels of LPA prevent MIXL1-GFP expression. d Flow cytometry histograms of SSEA-3 expression for cells grown in 3 µM CHIRON+ 0.48 µM
LPA with IWP-2 (blue) or without IWP-2 (orange). Histograms are from 3 days in culture and 3 days post first passage. SSEA-3 was maintained post
passage in samples cultured with IWP-2 present only. e A schematic diagram of the development of PRIMO medium. Cells grown under GSK3B inhibition
supplemented with LPA and with or without IWP2 induce expression of MIXL1-GFP(+)/SSEA-3(+) cells after 3 days. Post passage without IWP-2 addition
cells differentiate, losing SSEA-3, but with IWP-2 cultures maintained SSEA-3 and some MIXL1 expression. f After optimisation, the new formulation
consisted of 3 µM CHIRON, 1 µM IWP-2 and 0.48 µM LPA. Density plots display the MIXL1/SSEA-3 expression under PRIMO revealing high double
expression.
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Fig. 4 Cells in PRIMO transcriptionally correlate with the MEF/KOSR substate and early mesodermal differentiation. a Principal component analysis of
MIXL1-GFP(+)/SSEA-3(+) (dark purple stars) and MIXL1-GFP(−)/SSEA-3(+) (light purple stars) cells grown in PRIMO compared to the fractions
identified in MEF/KOSR conditions (circles) and standard E8 culture (grey squares). b t-Distributed Stochastic Neighbour Embedding (t-SNE) plots of the
expression of 45 genes in individual cells measured by Fluidigm Biomark qPCR and analysed by Monocle2. Displays all fractions in the same dimensional
space from MEF/KOSR conditions (presented in Fig. 1c) MIXL1-GFP(−)/SSEA-3(+) cells as red squares, MIXL1-GFP(+)/SSEA-3(+) cells as green circles,
MIXL1-GFP(−)/SSEA-3(+) cells as blue triangles and PRIMO conditions MIXL1-GFP(+)/SSEA-3(+) cells as purple stars. c Flow cytometry dot plot of the
emerging population for which was sorted at the indicated timepoints during a differentiation time-course. Differentiation was induced incubating cells with
E8 containing CHIRON at 3 µM for 72 h. d Principal component analysis of MIXL1-GFP(+)/SSEA-3(+) (dark purple stars) and MIXL1-GFP(−)/SSEA-3(+)
(light purple stars) cells grown in PRIMO compared to the differentiation time course (coloured squares). e Gene expression scatter plot of bulk RNAseq
analysis of cells grown in E8 compared to PRIMO medium. Differentially expressed genes were identified by DESeq2 with a cut off p value of <0.05 (blue
squares) and the SeqMonk intensity difference filter with a p value cut off <0.05 (red squares). Some key genes related to pluripotency are shown as green
squares. f Gene ontology (GO) statistical enrichment analysis was performed by ToppGene64 and Revigo62 on the list of genes from the SeqMonk59
intensity difference filter. GO terms which were significantly enriched are shown, the Log10 p values for each GO term are displayed. GO terms related to
early differentiation and gastrulation are significantly enriched. b, e Source data are provided as a Source Data file.
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PRIMO retain full pluripotency, despite their mesoderm bias
under neutral differentiation conditions.
PRIMO Plus maintains a mesoderm biased pluripotent state.
To confirm that we could maintain human PSC in a biased
substate through successive passages, we analysed HES3-MIXL1
ES cells after three passages in PRIMO Plus medium. In addition,
we also transitioned into PRIMO Plus medium another human
PSC line, H9 T-Venus and a human IPS cell line, MIFF131, and
likewise maintained them through three passages. In each case,
the cells retained an undifferentiated morphology and expressed
high levels of SSEA-3 (Fig. 7a–c). The HES3-MIXL1 cultures
retained, as before, a population of MIXL1-GFP(+)/SSEA-3(+)
cells (Fig. 7a), while the H9 T-Venus cultures contained a
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MIXL1-GFP(−)/SSEA-3(+), and put through a neutral EB assay. After 7 days EBs were harvested and assessed for gene expression by hPSC scorecards.
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b, d Source data are provided as a Source Data file.
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substantial population of T (Brachyury) (+) cells, this population
being more consistently abundant than the MIXL1-GFP(+)
population (Fig. 7b), whereas in E8 medium there were no
MIXL1-GFP(+) (Fig. 3a) or T (Brachyury) (+) cells (Supple-
mentary Fig. S12a). These cells also expressed a typical set of
pluripotency-associated genes that were down regulated when the
cells were allowed to form EBs under neutral differentiation
conditions. At the same time, the pattern of induced gene
expression indicated a strong mesoderm bias in the differentia-
tion of each of the lines (Fig. 7d). These results confirm that in the
optimised PRIMO Plus medium, human pluripotent stem cells
can be maintained following passaging in a mesoderm biased
substate within the stem cell compartment.
PRIMO Plus remained our optimal medium, but we also tested
whether we could substitute components for others that targeted
the same or similar pathways. Using H9 T-Venus reporter we
found that recombinant Dickkopf WNT signalling Pathway
Inhibitor 1 (DKK1), which inhibits WNT ligand binding to WNT
receptors, could be used at 100 ng/mL in place of IWP-2
(Supplementary Fig. S12b). Similarly, CHIR99021 could be
substituted with the GSK3β inhibitor SB216763 at 10 µM
(Supplementary Fig. S12c). For replacement of LPA we focused
on activators of G-Coupled Protein receptors. We used various
concentrations of Sphingosine-1-phosphate (S1P), another phos-
pholipid present in KOSR medium that has been shown to inhibit
differentiation23,32, and a chemical agonist for LPA receptor 2
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(GRI977143)33. The cell expression patterns observed using S1P
or GRI977143 media were similar to that observed using LPA-
based media, albeit at slightly different concentrations (Supple-
mentary Fig. S12d, e).
We returned to our PRIMO Plus formulation to assess the
phenotypic and genetic stability of these lines in extended culture.
The results showed that the pluripotency associated surface
markers SSEA-3, SSEA4, THY1 and TRA-1-81 were highly
expressed in HES3-MIXL1 at passage 7 and H9 T-Venus at
passage 10 (Supplementary Fig. S13a, b). H9 T-Venus cells were
also assessed at passage 3 in PRIMO Plus for their NANOG and
SOX2 expression by immunofluorescence, revealing high co-
expression of these markers with T-Venus (Supplementary
Fig. S14). Further, both HES3-MIXL1 and H9 T-Venus cells
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growing in PRIMO Plus maintained a normal diploid karyotype
after ten passages, assessed by G-banding and scoring 30
metaphase spreads (Supplementary Fig. S15)
To assess further how the long term passaged, mesoderm
biased cells related to the trajectory of mesoderm differentiation
induced by CHIRON we performed bulk RNA-seq analysis on
the MIXL1-GFP(−)/SSEA-3(+) and MIXL1-GFP(+)/SSEA-3(+)
HES3-MIXL1 cells from cultures maintained in PRIMO Plus for
10 passages (Supplementary Fig. S13c). We compared these data
(Fig. 7e) to our previous analysis of the time course of
differentiation induced by CHIRON and also cells cultured
PRIMO cultures for just 3 days (Fig. 4d). The transcriptome of
both the MIXL1-GFP(+)/SSEA-3(+) and MIXL1-GFP(−)/SSEA-
3(+) cells after ten passages in PRIMO Plus correlated with cells
located between 18 and 24 h on the differentiation trajectory,
similar to the previously assessed cells after 3 days in PRIMO
medium.
Further, we show crucially that when cells were transitioned
back into E8 medium after nine passages in PRIMO Plus, these
induced transcriptional changes reverted to expression levels
typical of cells maintained in E8 medium. At the same time,
MIXL1-GFP/SSEA-3 expression similarly reverted (Supplemen-
tary Fig. S13d). Assessing a sample of genes related to
pluripotency and mesendoderm differentiation reveals a pattern
of expression shared by PRIMO cultures and lost in reverted
cultures. Mesendoderm genes such as T, EOMES, NODAL, etc.
are all highly expressed in PRIMO cultures and lowly or non-
expressed in both E8 and reverted cultures. Pluripotency
associated genes such as NANOG, POU5F1, SOX2 and DNMT3B
have less varied expression levels across all samples (Fig. 7f), the
protein expression of NANOG and SOX2 was also validated by
immunofluorescence in PRIMO Plus and reverted cultures
(Supplementary Fig. S16). The growth rates and morphology of
cells were also monitored by time lapse microscopy showing
consistent growth in all conditions. (Supplementary Fig. S17).
Another key question is the extent and ease with which
mesoderm biased stem cells that have been maintained for
multiple passages in PRIMO medium revert to a non-lineage
biased pluripotent state when transferred back to standard E8
medium. When both HES3-MIXL1 and H9 T-Venus cells were
transferred to E8 medium after multiple passages in PRIMO,
SSEA-3 expression was maintained but reporter expression was
substantially reduced highlighting the plasticity of the mesoderm
biased stem cell state (Supplementary Fig. S18). To confirm that
the transcriptional reversion seen upon the transfer of cells from
PRIMO to E8, was accompanied by functional reversion, neutral
EBs were generated from PRIMO Plus and reverted cultures.
Whereas with both cell lines a strong mesoderm bias was seen in,
the EBs produced from cells kept in PRIMO Plus, the bias was
diminished in the cells transferred to E8 medium with strong
gene expression signatures from all three germ layers (Fig. 7g).
This demonstrates how easily cells can move through these
substates of pluripotency, leading to functional consequences in
their differentiation potential.
Discussion
One view to accommodate the apparent heterogeneity of human
PSC is that the stem cell compartment comprises several inter-
convertible substates in which the cells retain pluripotency but
behave transiently as differentiation intermediates, with distinct
propensities for differentiation and lineage selection. We have
now identified a mesoderm biased state within human plur-
ipotent stem cell compartment, which we can induce and main-
tain in PRIMO, a defined medium based on cross antagonism, i.e.
simultaneously applying signals that promote differentiation
(GSK3-β inhibition) and pluripotency (LPA) (Fig. 8). This state
exhibited characteristics corresponding to undifferentiated cells,
demonstrated through their capacity to generate clonally derived
lines that retain pluripotency. Examining the transcriptome, by
bulk and single cell approaches, highlighted co-expression of
pluripotency and differentiation associated gene regulatory net-
works within the substate. This substate could be induced in three
independent human PSC lines and remained stable over multiple
passages.
The cells induced by PRIMO medium appear to be relevant
normal intermediates in the differentiation of human PSC
towards mesoderm, as their transcriptome is positioned between
18 and 24 h on the time course of induced mesoderm differ-
entiation. Although initially we defined the state using MIXL1
expression, cells in PRIMO were heterogeneous for MIXL1-GFP
expression whereas T(Brachyury) was more widely expressed as
judged by the T-Venus reporter. When compared to our
Fig. 7 Cells in PRIMO medium can be maintained in a mesoderm biased state and revert back to an unbiased state. Flow Cytometry analysis of cells
grown in PRIMO Plus for three passages. a Density plot of MIXL1-GFP vs SSEA-3 for HES3 MIXL1 b Density plot of T-Venus vs SSEA-3 for H9 T-Venus
c. Histogram of SSEA-3 expression for MIFF1. d Algorithm score for EBs generated from HES3-MIXL1, H9 T-Venus and MIFF1 (iPS line) grown in PRIMO
medium for three passages. All lines exhibited strong mesoderm signatures under neutral conditions (n= 1 biological repeat from three separate lines).
e Principal component analysis of cells grown in PRIMO for 3 days (purple stars) or ten passages (purple triangles) compared to the differentiation time
course (grey squares). Also shown are cells, which had been grown in PRIMO for nine passages and then transitioned back into E8 conditions (red and
orange triangles). Cells maintained in PRIMO cultures are close to 18–24 h of differentiation and reverted cultures close to 0 h (E8 only) cultures (white
circles). f Heatmap analysis of key genes related to Pluripotency and mesendoderm differentiation generated with Log2 counts that have been mean
centred per gene with a colour scale from −2 to 2. g Lineage proportion graphs from neutral EBS generated from HES3-MIXL1 and H9 T-Venus after three
passages in PRIMO Plus and subsequent reversion into E8 medium. The strong mesoderm bias was alleviated upon transition back into standard
conditions. b, d, e Source data are provided as a Source Data file.
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Fig. 8 A schematic diagram of the trapping of a Mesoderm Biased Human
PSC (hPSC). The cross antagonism of the pro-pluripotency factor (LPA)
and pro-differentiation factor (GSK3β Inhibition) is able to induce a
mesoderm biased state in human PSC but endogenous WNT secreted by
the cells drives further differentiation. Using IWP-2 to block this
endogenous WNT secretion prevents this further differentiation. These
three components of PRIMO medium permit the maintenance of the
mesoderm biased state in vitro.
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differentiation time course MIXL1-GFP(+) and MIXL1-GFP(−)
cells both sit on the trajectory with the MIXL1-GFP(+) cells
sitting slightly further on the trajectory. Importantly MIXL1-GFP
(−) cells grown in PRIMO, like their MIXL1-GFP(+) counter-
parts, displayed a strong mesoderm bias in neutral EB assays, in
contrast to the MIXL1(−) cells grown in E8 medium.
LPA and CHIRON have been used in combination before by
Blauwkamp et al.22 in an attempt to enhance differentiation
efficiency through reducing heterogeneity of WNT expression in
human ES cultures. Our goal was to trap cells in a mesoderm
biased intermediate state using LPA and CHIRON but CHIRON
induction produces a positive feedback loop, since the derivative
cells themselves produce WNT ligands which drives further dif-
ferentiation. Indeed, our single cell transcriptomic analysis,
showed expression of endogenous WNT related genes, consistent
with the notion that early differentiation would lead to the
secretion of WNT ligands which would confound our ability to
precisely regulate WNT activation with CHIRON. To counteract
this positive feedback loop, we reasoned that we could incorpo-
rate a Baseline Activation approach24.
Baseline Activation as an approach focuses on blocking the
endogenous signalling that allows an exact titration of the signal
by addition of exogenous agonist, affording tighter control. We
used IWP-2 to inhibit WNT ligand secretion, or DKK1 to block
WNT ligand binding, while activating the pathway with CHIRON
or SB216763. This strategy enabled us to stabilise cultures in
PRIMO medium and maintain the cells in this transitory plur-
ipotent state that exhibited mesoderm bias (Fig. 6e). Bakre et al.
described a seemingly similar mesoderm biased state in mouse
PSC induced into a mesoderm biased state through manipulation
of WNT signalling34. However, reversion of their cells to an
unbiased state took two weeks of culturing. While the generation
or identification of multipotent progenitors towards mesoderm
and endoderm from PSC has been demonstrated previously in
human35–37 PSC in vitro, these studies indicated a loss of tradi-
tional pluripotent markers such as NANOG, POU5F1 and SOX2
and a lineage restricted differentiation potential, representing
trapping of later stages of differentiation. An important distinc-
tion is that the substate we describe here is plastic with cells being
able to further differentiate or, when returned to E8 medium,
readily revert to an unbiased stem cell state demonstrated both by
reversion of the transcriptional profile and reacquisition of
unbiased differentiation in EB assays. Nevertheless, retention of
pluripotency of the cells in the substate was shown by their ability
to generate ectoderm, endoderm or neural crest, under appro-
priate differentiation conditions.
Taken together our results suggest that the intermediate we
have trapped sits on a normal in vitro differentiation trajectory
the investigation of which may lend further insight into the cri-
tical events that ultimately lead to the exit from pluripotency.
How this intermediate relates to the differentiation within the
human embryo remains unclear. Interestingly, cells in PRIMO
express certain lineage markers including T and MIXL1 that are
expressed in a subset of mouse epiblast stem cells that are derived
from the post-implantation embryo38–40. It is plausible that this
similarity in the transcriptome reflects correspondence to a
similar developmental intermediate in the human embryo. These
considerations aside, we wish to emphasise that these cells
represent a key in vitro intermediate in the differentiation of
human PSC that has practical implications for production of cells
for use in regenerative medicine. In considering the application of
this medium in translation medicine, we envisage that limited
passaging in PRIMO would be sufficient to bias a population of
human PSC prior to differentiation. From our experience of
growing cells in PRIMO Plus the generation of more than 1010
cells after even only three passages from an initial seeding of one
million cells is possible. Whilst we have demonstrated cells
remained genetically stable over ten passages suggesting the
medium may be safe for scale up, the state induced appears
similar even after a short period in the medium suggesting
extended passaging in PRIMO may not be necessary. The system
of cross-antagonism within the controlled environment of base-
line activation that we have used to generate a mesoderm-biased
substate of human PSC could, in principle, be used to generate
other lineage-biased substates or facilitate the capture of relevant
differentiation intermediates at later developmental stages.
Methods
Cell culture. Four human PSC lines were used in this project, ES cell lines, HES341,
HES3-MIXL111 and H9 T-Venus27, and iPSC line, MIFF131. Both feeder and feeder
free systems were used. For either system, flask/plates of hESCs were grown in
humidified incubators at 37 °C and 5% CO2. Our feeder culture system uses a layer
of mitotically inactivated mouse embryonic feeders and KOSR medium consisting
of KnockOut DMEM (ThermoFisher), 20% KnockOut Serum Replacement
(Thermofisher), 1x Non-essential amino acids (ThermoFisher), 1mM L-Glutamine
(ThermoFisher), 0.1 mM 2-Mercaptoethanol (ThermoFisher) and 4 ng/ml FGF2
(Peprotech) and is referred to as MEF/KOSR conditions. For feeder free systems we
used two matrices Geltrex (ThermoFisher) and Vitronectin (Stem cell Technolo-
gies). This was combined with E8 medium (made in house, adapted from Chen
et al.20) with L-Glutamine being replaced for the more stable GlutaMax (Ther-
moFisher). For LPA containing and subsequent PRIMO media, the LPA media is
first made as a 10× stock in E8 medium, 10× BCL (BSA, Cholesterol, LPA) at 1%
Fatty acid Free BSA (Probumin, Millipore), 20 µM Cholesterol (Synthechol, Sigma)
and 4.8 µM Oleoyl-L-α-lysophosphatidic acid sodium salt (LPA, Sigma). This was
then diluted in E8 as needed for PRIMO and PRIMO Plus, then CHIRON 99021
(Tocris) and IWP-2 (Tocris) were added at 3 µM and 1 µM, respectively. A detailed
protocol for medium preparation and passaging in PRIMO Plus has been uploaded
to Nature protocol exchange42. Cells for MEF/KOSR were passaged by treatment
with Collagenase IV (ThermoFisher) and manually scrapped away. Cells for feeder
free systems were passaged with a non-enzymatic disassociation solution ReLeSR
(Stem Cell Technologies) according to manufacturer’s instructions.
Flow cytometry. Single cell suspensions were harvested by treating with accutase
(ThermoFisher) for 10 min, then washed and resuspended in Dulbecco’s Modified
Eagle’s medium (DMEM) and 10% Foetal Calf Serum (FCS) at a density of 1 × 107
per mL. Antibodies were added at the appropriate dilution. After addition of the
primary antibody cells were incubated at 4 °C for 30 min. Cells were then washed
with DMEM/FCS and resuspended in DMEM/FCS. Secondary antibody, Goat anti
Mouse Affinipure IgG+ IgM (H+ L) Alexafluor 647 (Jackson Laboratories) at
1:200 and incubated at 4 °C for 30 min. Cells were then washed and resuspended in
fresh DMEM/FCS for flow cytometry analysis. To set baselines for MIXL1-GFP
and negative secondary 647, unlabelled HES3 line was harvested and stained for
P3X. P3X is an IgG1 antibody that is secreted from the parent myeloma,
P3X63Ag8, from which all in house hybridomas had been derived43. P3X shows
minimal reactivity to human cells43. Positive gates were set according to HES3 P3X
negative controls. Samples were also stained for P3X to assess non-specific binding.
All flow cytometry analysis contained P3X samples for baseline setting (source
data). The monoclonal antibodies BF444, CD9(CH8)44, SSEA-345, SSEA-446, THY1
(CD90)47, TRA-1-6048, TRA-1-8148 and TRA-2-4949 were prepared in house from
the relevant hybridomas as previously described16,47.
Intracellular staining. Cells were fixed using 4% PFA for 15 min and permeabi-
lised with 0.5% Triton X-100 in PBS (w/o Ca+, Mg+ +) with 10% FCS and 0.1%
BSA for 10 min. Cells were washed and then incubated with blocking buffer
consisting of 10% FCS and 0.1% BSA in PBS (w/o Ca+, Mg+ +) for one hour.
Cells were then washed, primary antibody was added and they were incubated
overnight at 4 °C. Antibodies used were: Anti-NANOG (XP® #4903, Cell Signalling
Technology, 1:400), ANTI-SOX2 (XP® #3579, Cell Signalling Technology, 1:400)
and Anti-SOX10 (Cell Signalling Technology, 89356S, 1:500). Secondary anti-
bodies, Goat anti Mouse Affinipure IgG+IgM (H+ L) Alexafluor 647 (Jackson
Laboratories) or Goat anti Rabbit Affinipure IgG+IgM (H+ L) Alexafluor 594
(Jackson Laboratories) at 1:200 and incubated at 4 °C for 2 h min. Hoescht 33342
(ThermoFisher, #H3570) was added at 1:10000 or DRAQ5 at 1:1000 to the diluted
secondary antibody solution. Samples were imaged on an INCell 2200 (GE
Healthcare) and analysed on Cell Profiler v2.250. Density plots of expression were
generated using FlowJo v10.651.
Live TRA-1-81 staining. In order to assess the progress of the clonal line formation
we performed live staining for a pluripotency-associated surface marker TRA-1-81.
Lines were assessed after the first passage into 48 well plates. TRA-1-81 antibody
was added to warm KOSR medium at 1:10 dilution and incubated at 37 °C for 30
min. Wells were then washed twice with KOSR medium before medium containing
secondary antibody, Goat anti Mouse Affinipure IgG+IgM (H+ L) Alexafluor 647
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(Jackson Laboratories) at 1:200 was added to each well, cells were incubated at
37 °C for 30 min. Wells were then washed once with KOSR medium and twice with
FluoroBrite DMEM (ThermoFisher). After imaging the medium was replaced with
fresh KOSR medium and returned to 37 °C incubator.
Single cell cloning. 96 well plates were coated with 0.1% gelatine and a layer of
mouse embryonic feeders. Cells were harvested using accutase (ThermoFisher).
After staining for flow cytometry, DAPI was added at 1:10,000 and used for live/
dead discrimination. After gating on the BD Sortware programme (Supplementary
Fig. S19c, d) the desired population was sorted as single cells directly into 96 well
plates. The sort was indexed to retain information regarding the MIXL1-GFP and
SSEA-3 expression levels. For single cell cloning the medium differed from stan-
dard culture. For this we used a 50/50 mix between standard KOSR medium and
mTESR medium (Stem Cell Technologies) and the addition of 20 µM Synthechol
(Sigma). During initial plating 10 µM of Rock Inhibitor (Y-27632, Generon) was
added to the medium. Immediately after sorting into the wells the plates were
centrifuged at 200 g for 1 min to aid attachment of the cells. After 2 days the
medium was replaced with fresh medium to remove the ROCK inhibitor. Colonies
were left to develop over 9–12 days before passaging the wells which looked to
contained typical human PSC colonies. Colonies were passaged from 96 well plate
into a 48 well plate by manual scrapping with a p200 tip, then aspirating and
dispensing the dissected colony into one well of a 48 well plate. This 50/50 mix
medium was used to grow clones until lines appeared to be growing stably, often up
to the third passage before changing into standard KOSR medium.
Embryoid bodies in neutral conditions. To assess the trilineage potential, we used
an approached which entailed the formation of Embryoid Bodies (EB) under
neutral conditions, in this context neutral simply indicates that no exogenous
cytokines or chemicals were added to guide differentiation. Cells were either used
directly from flasks or after they had been FACS sorted for a particular population
(Supplementary Fig. S19e). In either situation cells were resuspended in APEL 2
medium (Stem Cell Technologies) containing 10 µM of Rock Inhibitor (Y-27632,
Generon) Cells were resuspended at 3000 cells per 50 µL. 50 µL of cells were added
to non-adherent Grenier U bottom 96 well plate. After adding the cells plates were
centrifuged at 200 g for 3 min, to pellet cells. Plates were incubated at 37 °C, 5%CO2
for 7 days. After 7 days EBs were dissolved in Trizol and RNA extracted using the
Norgen Total RNA Purification Kit. The RNA was converted to cDNA using the
High Capacity cDNA Reverse Transcription Kit (Thermofisher). The samples were
then loaded and run on the hPSC scorecards (ThermoFisher), results were analysed
by ThermoFisher’s scorecard software. Algorithm scores for EBs were normalised
to the same cell line growing in E8 conditions.
Directed embryoid body differentiation. Differentiation protocols were adapted
from Allison et al.4. Cells were prepared in the same manner as for the neutral EBs.
APEL2 medium containing 10 µM of Rock Inhibitor (Y-27632, Generon) was
supplemented with these reagents for each lineage; ectoderm (1 μM DMH1
(Tocris), 10 μMSB431542 (Tocris) and 100 ng/ml basic-FGF(Peprotech)), endo-
derm (100 ng/ml Activin-A (Peprotech), 1 ng/ml BMP4(Thermofisher) and
mesoderm (20 ng/ml Activin-A (Peprotech), 20 ng/ml BMP4 (Thermofisher). EBs
using the H9 T-Venus line were also supplemented with 1 μM IWP-2 (Tocris). EBs
plates were placed in an incubator at 37 °C and 5%CO2 for 10 days, then harvested
and analysed by the hPSC scorecard method as per the neutral EBs.
Neural crest differentiation. Neural crest protocol was adapted from Hackland
et al.24. Cells were harvested and plated at 40,000 cells/cm2 on wells coated with
Geltrex (Thermofisher) in neural crest medium (DMEM/F12 basal, Sigma, 1×
N2 supplement, Thermofisher, 1× Non-essential Amino Acids, Thermofisher, 1×
GlutaMax, Thermofisher, 2 µM SB431542, Tocris, 1 µM CHIR99021, Tocris, 1 µM
DMH1, Tocris and BMP4 15 ng/ml, Gibco). Cells were plated either with 10 µM of
Rock Inhibitor (Y-27632, Generon) or without Rock Inhibitor and 1 µM of IWP-2
(Tocris) for the first 48 h. Plates were placed in an incubator at 37 °C and 5%CO2.
Medium was replaced after 48 h with fresh neural crest medium. Medium was
replaced every other day. Cells were fixed on the 5th day of neural crest differ-
entiation and stained for SOX10 (Cell Signalling Technology, 89356S, 1:500).
Blood differentiation. The differentiation towards blood lineage precursors has
been described previously52,53. Prior to the differentiation cells were split into flasks
containing E8 or PRIMO Plus medium and left to grow for three days.
OP9 stromal cells were grown in 10 cm dishes coated with 0.1% gelatine in OP9
growth medium (α-MEM (ThermoFisher), 10% Foetal Bovine serum (Thermo-
fisher), 100 µM monothioglycerol (Thermofisher) and 100 U/mL of
Penicillin–Streptomycin (Thermofisher)) until they had reached confluency.
Human PSC were harvested as clumps by treatment with collagenase IV for 10–30
min and scraping from the flasks. A sister flask of both conditions was analysed for
reporter gene and SSEA-3 expression by flow cytometry. Human PSC were seeded
onto confluent layer of OP9 cells in OP9 growth medium. Medium is replaced fully
(20 mL) on day 1, then half changes (10 mL) on day 4, 6 and 8. After 10 days, cells
were harvested and stained with CD147 APC-conjugated antibody (R&D Systems,
FAB3195A, 1:100), CD43 PE-conjugated antibody (Biolegend, 343203, 1:00) and
CD34 PECy7-conjugated antibody (Biolegend 343516, 1:160). Cells were analysed
by flow cytometry and firstly gated on the pan-human marker CD147 to remove
signal from remaining OP9 stromal cells.
Differentiation time course. Cells growing in E8 medium were supplemented
with 3 µM CHIRON 99021 (Tocris) one day post passage. Cells were collected and
stained with anti-SSEA-3 antibody at time points 6, 12, 18, 24, 48 and 72 h. Cells
were sorted directly into Trizol. The medium was refreshed after 48 h with fresh E8
containing 3 µM CHIRON.
Bulk sorting and RNA sequencing. We sorted using a BD FACS Jazz (Supple-
mentary Fig. S19f, g) or FACS Aria III (Supplementary Fig. S19a, b), we first began
by sorting 10,000 cells from a given population into an eppendorf tube containing
200 µL DMEM/FCS. 1,000 cells are then reanalysed from this sorted fraction to
ensure accurate sorting has taken place. Immediately after a successful reanalysis,
10,000 cells from the given population are sorted into an eppendorf tube con-
taining 800 µL Trizol. Post sort, samples were sealed, vortexed and stored at −80 °C
until extraction. Total RNA was extracted from the aqueous phase of thawed Trizol
(Thermo Fisher) lysates after addition of 160 µl chloroform and precipitated by
mixing an equal volume of isopropanol supplemented with 10ug of linear poly-
acrylamide (Sigma). The RNA pellet was washed twice with 70% ethanol and
resuspended in water. Total RNA was quality controlled and quantified using
Bioanalyzer RNA 6000 Pico chip kit (Agilent). 1.5 ng total RNA was used with
SMARTer.v3 or SMART-Seq.v4 kits (Clontech) to prepare cDNA libraries as per
supplier instructions. cDNA libraries were purified with Agencourt AMPureXP
(Beckmam) magnetic beads (at 0.8 bead to 1 cDNA ratio), washed twice with fresh
80% ethanol and eluted in EB buffer. Each of the cDNA libraries were quality
checked using Fragment Analyzer High Sensitivity Large Fragment kit (Agilent),
and quantified using Qubit High Sensitivity DNA kit (Thermo Fisher). 150 pg of
each cDNA was used to prepare sequencing libraries with Nextera XT DNA
Preparation Kit and Indexing primers (Illumina), but following a slightly modified
version of the manufacturer’s protocol involving fourfold volume miniaturisation
throughout (12.5ul final volume). Nextera-XT indexed sequencing libraries were
purified with Agencourt AMPureXP magnetic beads (at 0.8 bead to 1 cDNA ratio),
washed twice with fresh 80% ethanol and eluted in EB buffer. Each of the indexed
libraries were quality checked using Fragment Analyzer High Sensitivity Large
Fragment kit, and quantified using Qubit High Sensitivity DNA kit. Indexed
sequencing libraries were pooled to be equimolar. Library pools were quality
checked using Bioanalyzer High Sensitivity DNA kit (Agilent), and quantified
using Qubit High Sensitivity DNA kit before running out at 2pM on NextSeq High
Output flow cells using 76-cycle paired-end sequencing of inserts. These indexed
pools were demultiplexed through Illumina BaseSpace to provide pass-filter
FASTQ output sample files. Raw fastq files from the RNA-seq experiments were
run through a processing pipeline beginning with QC using FastQC v 0.11.554.
Following initial QC the reads were aligned using HISAT2 v2.1.055 to the human
reference genome GRCh3856. Post-alignment QC and feature counts were per-
formed using QoRTs v1.1.857 and feature quantification was done with cufflinks v
2.2.158. Gene expression data was then analysed by Seqmonk v1.4659 to produce
heat maps and clustering. Differential gene expression analyses was performed
using DESeq260 and Seqmonk intensity difference filter59. Gene Ontology
enrichment was performed by ToppGene61 and ReviGO62.
Single cell qPCR. Samples were sorted using the flow cytometer, BD FacsAria III
(Supplementary Fig. S19a, b). DAPI (Sigma) or Propidium Iodide (Sigma) was
added for live/dead discrimination. Sorting population gates were set in the flow
cytometry software, FACS DIVA, based on GFP expression (488 nm laser), and
SSEA-3 (stained with Alexafluor 647 secondary antibody) expression (635 nm
laser). Single cells from each selected substate were then directly deposited into 96
well plate with 4 µl of lysis buffer (65 µM of dNTP mix (Invitrogen 10297-018),
0.4% of NP40 (Sigma N-3516), 2.4 mM DTT (Invitrogen), 0.5 U/µl RNAseOUT
(Invitrogen 10777-019) in nuclease-free water). cDNA synthesis and target specific
pre-amplification was done using Cell Direct one-step qRT-PCR kit (Invitrogen 46-
7201). Pre-amplification mastermix was added to each well; 6.25 µL of 2X Reaction
Buffer, 1 µl of SuperScript III RT/Platinum Taq mix (Invitrogen 55549) and 1.5 µl
of TaqMan assay mix. TaqMan assay mix was prepared by mixing equal volume of
all target specific primers (Supplementary Table S1). No-RT controls were pre-
pared with PlatinumTaq Polymerase (Invitrogen, 100021272) and no SuperScript
III RT enzyme was included. The PCR conditions were: 60 min at 50 °C, 2 min at
95 °C and 25 cycles of 15 s at 95 °C and 4 min at 60 °C. Pre-amplified product was
diluted 1–5 and loaded onto a 48.48 chip together with Taqman universal Mas-
terMix (Applied Biosystems 4304437) and the Taqman assays listed in (Supple-
mentary Table S1) with the appropriate loading reagents according to
manufacturer’s instructions (BioMark 48.48 Dynamic array platform (Fluidigm).
Single cell qPCR analysis was performed by two pieces of software. Prior to analysis
cells were screened and cells with particularly high CT values (>30) for the
housekeeping genes ACTB and RPS18 were removed, across all experiments 9 of
320 single cells were removed. We verified expression of genes with extra wells
containing 10 cells rather than single cells, MMP1 was removed from analysis, as it
showed no expression in any samples. Depending on the application being used,
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some pre-processing was performed. For Monocle2 software18 and subsequent T-
SNE plots, 999 values were set to 40, as this is the maximum number of cycles on
the PCR machine. We used Genesis software63 for heatmap production, where 999
values were removed and Z-scores were computed from all remaining values. For
each gene, Z-scores were calculated using this formula: (Ct value –Ct mean)/
standard deviation Cts.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
RNA sequencing data that supports the findings of this study have been deposited in the
ArrayExpress database at EMBL-EBI under the accession number E-MTAB-9474. All
other supporting data are available from the corresponding author upon request. Source
data are provided with this paper.
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